ALL-TRANS RETINOIC ACID INDUCED MYOCARDITIS AS PART OF DIFFERENTIATION SYNDROME: A CASE REPORT AND LITERATURE REVIEW

EHA Library, Na Kim, 324105

THERAPY-RELATED MYELOID NEOPLASMS: A DESCRIPTIVE ANALYSIS AT A SINGLE INSTITUTION

EHA Library, BEATRIZ MERCHAN MUÑOZ, 324106

TAGRAXOFUSP AS FIRST-LINE TREATMENT OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN). A CASE REPORT

EHA Library, Clara Navajas Laguna, 324107

TWO CASE REPORT: CONCURRENT CROHN'S DISEASE AND MYELODYSPLASTIC SYNDROME OR ACUTE LEUKEMIA

EHA Library, Zaineb Mlayah, 324108

THE CORRELATION BETWEEN SKIN RESPONSE AND BLOOD INVOLVEMENT WITH MOGAMULIZUMAB

EHA Library, Pietro Quaglino, 324109

CAR-T CELL THERAPY FOR PEOPLE WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A COCHRANE SYSTEMATIC REVIEW

EHA Library, Moritz Ernst, 324110

RELATIONSHIP BETWEEN GENETIC ABERRATIONS IN THE 17P13/TP53 LOCUS AND IMMUNOHISTOCHEMICAL PROTEIN P53 EXPRESSION IN TUMOR CELLS OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Maria Sarpova, 324111

RELATIONSHIP BETWEEN PAKT1, PSYK PROTEINS CO-EXPRESSION AND SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Elena Vaneeva, 324112

ABNORMAL AND COMPLEX KARYOTYPE IS FREQUENT ON ROUTINE KARYOTYPING ON PRIMARY TISSUE IN PATIENTS WITH DIFFUSE LARGE B-CELL AND TRANSFORMED LYMPHOMA BUT DOES NOT INFLUENCE CLINICAL OUTCOMES

EHA Library, Ray Mun Koo, 324113

ESCALADE: ACALABRUTINIB + RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AND PREDNISONE (R-CHOP) IN UNTREATED NON-GERMINAL CENTER B-CELL–LIKE (NON-GCB) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Laurie Sehn, 324114

BENDAMUSTINE IS A FAVORABLE LYMPHODEPLETING CHEMOTHERAPY REGIMEN PRIOR TO CAR T CELLS IMMUNOTHERAPY AS FLUDARABINE

EHA Library, Peihao Zheng, 324115

DISPARITIES IN LYMPHOMA SURVIVORSHIP ACCORDING TO SOCIO-DEMOGRAPHIC FACTORS; SINGLE CENTER RETROSPECTIVE STUDY IN A COHORT OF 253 DLBCL PATIENTS TREATED WITH RCHOP

EHA Library, Emmanouil Spanoudakis, 324116

OUTCOME OF PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA AFTER HIGH-DOSE METHOTREXATE FOLLOWED BY CONSOLIDATION WHOLE-BRAIN RADIOTHERAPY AND CYTARABINE: AN 8-YEAR COHORT STUDY

EHA Library, Pokpong Piriyakhuntorn, 324117

NEUTROPHIL/LYMPHOCYTE RATIO (NLR) ITS A WORSE PROGNOSIS FACTOR IN OVERALL SURVIVAL IN LARGE B CELL LYMPHOMA (DLBCL). EXPERIENCE IN HEMATOLOGY CENTER IN NORTHEAST OF MEXICO

EHA Library, Guillermo Sotomayor Duque, 324118

HEALTH-RELATED QUALITY OF LIFE EFFECT OF MOGAMULIZUMAB BY PATIENT BLOOD INVOLVEMENT

EHA Library, Pier Luigi Zinzani, 324119

PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE PLUS RITUXIMAB VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) - LOTIS-5

EHA Library, Carmelo Carlo-Stella, 324120

BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN SUBJECTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) (TRIAL IN PROGRESS)

EHA Library, Nancy L. Bartlett, 324121

SAFETY AND FEASIBILITY OF HIGH DOSE CHEMOTHERAPY WITH PBSC RESCUE AND ASCT CONSOLIDATION IN PCNSL: A SINGLE CENTER EXPERIENCE

EHA Library, Emanuele Ravano, 324122

ACUTE TOXICITY OF R-CHOP PROTOCOL IN THE TREATMENT OF NON-HODGKIN'S LYMPHOMA : ABOUT 551 CYCLES

EHA Library, Emna Ines Saidi, 324123

LONG-TERM ANALYSES FROM L-MIND, A PHASE II STUDY OF TAFASITAMAB (MOR208) COMBINED WITH LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)

EHA Library, Johannes Düll, 324124

MANUFACTURING COMMERCIAL AXICABTAGENE CILOLEUCEL FOR EUROPEAN PATIENTS: A 2-YEAR RETROSPECTIVE ANALYSIS

EHA Library, Louis van de Wiel, 324125

RELATIONSHIP BETWEEN PAKT1, PSYK PROTEINS CO-EXPRESSION AND SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Elena Vaneeva, 324126

ТHE PROGNOSTIC ROLE OF PD-L1 PROTEIN EXPRESSION IN A COMBINED MODEL FOR PREDICTION OF THE SURVIVAL OF DIFFUSE LARGE B CELL LYMPHOMA PATIENTS

EHA Library, Svetlana Samarina, 324127

COPANLISIB IN COMBINATION WITH RITUXIMAB-BENDAMUSTINE IN PATIENTS WITH RELAPSED-REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A MULTICENTRIC PHASE II TRIAL OF THE FONDAZIONE ITALIANA LINFOMI (FIL_COPA-RB)

EHA Library, Mattia Novo, 324128

RADIOTHERAPY FOR SYSTEMIC B-CELL LYMPHOMA WITH CUTANEOUS INFILTRATION: IS IT WORTHY?

EHA Library, Ana Luisa Martins, 324129

DOSE-ADJUSTED EDOCH-RITUXIMAB IN ELDERLY PATIENTS WITH HIGH GRADE DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, BEATRIZ MERCHAN MUÑOZ, 324130

FRONT-MIND: A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY COMPARING EFFICACY AND SAFETY OF R-CHOP + TAFASITAMAB + LENALIDOMIDE VS R-CHOP ALONE FOR NEWLY-DIAGNOSED HIGH-RISK DLBCL

EHA Library, Umberto Vitolo, 324131

PRIMARY GASTRIC LARGE B CELL LYMPHOMA:EXPERIENCE OF THE HEMATOLOGY DEPARTMENT OF SFAX

EHA Library, Maha Charfi, 324132

FRONTLINE BRENTUXIMAB VEDOTIN AND CHP (A+CHP) IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA WITH LESS THAN 10% CD30 EXPRESSION (SGN35-032, TRIAL IN PROGRESS)

EHA Library, Deepa Jagadeesh, 324133

IMPLICATIONS OF IMMUNOMODULATORY MEDICATIONS IN COVID-19 INFECTED HEMATOLOGICAL MALIGNANCY PATIENTS IN QATAR

EHA Library, Afaf Al Battah, 324134

TREATMENT PATTERN AND PROGNOSIS ANALYSIS OF NEWLY DIAGNOSED T / NK CELL LYMPHOMA PATIENTS

EHA Library, Naoki Takahashi, 324135

SUCCESSFUL TREATMENT BRENTUXIMAB VEDOTIN OF CD30-NEGATIVE ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: CASE REPORT

EHA Library, Elena Lepik, 324136

DIFFUSE LARGE B-CELL LYMPHOMA AND HIGH-GRADE B-CELL LYMPHOMA: THERAPEUTIC RESPONSE - UNICENTRIC RETROSPECTIVE DESCRIPTIVE ANALYSIS

EHA Library, Bianca Castro, 324137

MYD88 EXPRESSION IN PRIMARY AND SECONDARY CNS LYMPHOMAS

EHA Library, berrin balik aydin, 324138

SUCCESSFUL MANAGEMENT OF EARLY CENTRAL NERVOUS SYSTEM RELAPSE IN A PATIENT WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA

EHA Library, Rostyslav Lozynskyy, 324139

BELINOSTAT IS WELL TOLERATED AND EFFICACIOUS IN A PATIENT WITH EARLY RELAPSED PERIPHERAL T-CELL LYMPHOMA: A CASE REPORT.

EHA Library, Michele Cimminiello, 324140

INCIDENTAL DIAGNOSIS OF BURKITT LYMPHOMA ON CECAL APPENDIX: CASE REPORT AND LITERATURE REVIEW

EHA Library, Sonia Mallano, 324141

INHIBITORS IN MILD HAEMOPHILIA A: EXPERIENCE OF A SINGLE SPANISH CENTER

EHA Library, Manuel Rodríguez López, 324142

ANALYSIS OF SURVIVAL IN PATIENTS WITH ACID SPHINGOMYELINASE DEFICIENCY TYPE B USING A LARGE, DEIDENTIFIED US ELECTRONIC HEALTH RECORD DATABASE

EHA Library, Amanda Wilson, 324143

TRANSTHORACIC AORTIC VALVE IMPLANTATION (TAVI) IN HEMOPHILIA

EHA Library, Manuel Rodríguez López, 324144

EVALUATION OF THE EFFICACY OF MOROCTOCOG ALPHA DURING THE PREVENTIVE TREATMENT OF PATIENTS WITH HEMOPHILIA A

EHA Library, Valery Voitsekhovsky, 324145

COVID INFECTION REVEALING FACTOR XI DEFICIENCY IN ELDERLY PATIENT

EHA Library, hajar khibri, 324146

APLASTIC ANEMIA PATIENTS COULD BE DIVIDED INTO TWO SUBGROUPS BASED ON THE GENE EXPRESSION IN THEIR BONE MARROW MULTIPOTENT MESENCHYMAL STROMAL CELLS

EHA Library, Alena Dorofeeva, 324147

IDENTIFICATION OF A NOVEL DELETION IN THE RPS26 GENE IN A GREEK CHILD WITH THE DIAGNOSIS OF BLACKFAN-DIAMOND ANEMIA

EHA Library, Iordanis Pelagiadis, 324148

PROFILE OF HEMOPHAGOCYTIC LYMPOHISTIOCYTOSIS (HLH) – PROSPECTIVE OBSERVATIONAL STUDY

EHA Library, Sirisharani Siddaiahgari, 324149

LONG-TERM EFFECTS IN SUBGROUPS OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN VERSUS ECULIZUMAB: 48-WEEK ANALYSIS OF PEGASUS PHASE 3 TRIAL

EHA Library, Régis Peffault de Latour, 324150

RHTPO IMPROVES THE OVERALL SURVIVAL OF PATIENTS WITH APLASTIC ANEMIA IN CHINA: RETROSPECTIVE ANALYSIS OF A SINGLE-INSTITUTION

EHA Library, rong Fu, 324151

MUTATION ANALYSIS OF CHINESE SPORADIC DIAMOND-BLACKFAN ANEMIA BY NEXT GENERATION SEQUENCING

EHA Library, Jing Li, 324152

IDIOPATHIC APLASTIC ANEMIA – ARE THERE OTHER PROGNOSTIC FACTORS?

EHA Library, Catia Reis, 324153

INJECTION-SITE REACTIONS AT WEEK 48 IN THE RANDOMIZED PHASE 3 PEGASUS TRIAL OF PEGCETACOPLAN COMPARED WITH ECULIZUMAB FOR INDIVIDUALS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Vivek Sharma, 324154

PH3 STUDY OF EFFICACY AND SAFETY OF IPTACOPAN (LNP023), AN ORAL COMPLEMENT FACTOR B INHIBITOR, IN PTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND RESIDUAL ANEMIA DESPITE ANTI-C5 ANTIBODY TREATMENT

EHA Library, Antonio Risitano, 324155

CATEGORIZED HEMATOLOGIC RESPONSE TO PEGCETACOPLAN VERSUS ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: POST HOC ANALYSIS OF PEGASUS PHASE 3 RANDOMIZED TRIAL DATA

EHA Library, Antonio Risitano, 324156

ASSOCIATION BETWEEN HLA AND BONE MARROW FAILURE DISEASES

EHA Library, Yuanyuan Shao, 324157

POST COVID 19 APLASTIC ANEMIA: CASE REPORT

EHA Library, Doaa El Demerdash , 324158

TWO CURRENTLY RECRUITING PHASE III TRIALS: COMMODORE 1 AND 2 EVALUATING CROVALIMAB VS ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WITH OR WITHOUT CURRENT ANTI–COMPLEMENT THERAPY

EHA Library, Austin Kulasekararaj, 324159

PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF IPTACOPAN (LNP023), AN ORAL FACTOR B INHIBITOR, IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) NAÏVE TO COMPLEMENT INHIBITOR THERAPY

EHA Library, Régis Peffault de Latour, 324160

PHENOTYPE-GENOTYPE RELATIONSHIP IN PATIENTS WITH FANCONI ANEMIA AND VACTERL-H ASSOCIATION FREQUENCY

EHA Library, Canan Albayrak, 324161

DIAGNOSIS OF HEMATOPOIETIC MALIGNANCIES WITH GERMLINE PREDISPOSITION : A FILTERED WHOLE EXOME SEQUENCING APPROACH

EHA Library, Rafael Fernandez Carazo, 324162

REAL WORLD SINGLE CENTRE EXPERIENCE OF USE OF ELTROMBOPAG ADDED TO STANDARD IMMUNOSUPPRESSION AMONG INDIAN PATIENTS WITH APLASTIC ANEMIA

EHA Library, Radhika K.K, 324163

COMPARATIVE EFFECTIVENESS OF PEGCETACOPLAN VERSUS RAVULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A MATCHING-ADJUSTED INDIRECT COMPARISON USING 26 WEEK PEGASUS PHASE 3 TRIAL DATA

EHA Library, Rachel Bhak, 324164

TRIAL IN PROGRESS: QUANTIFYING THE HUMANISTIC AND SOCIOECONOMIC BURDEN OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE COMMODORE BURDEN OF ILLNESS STUDY

EHA Library, Roger James Hampton, 324165

EPIDEMIOLOGY OF ACQUIRED APLASTIC ANEMIA: A RETROSPECTIVE 10-YEAR SINGLE CENTRE EXPERIENCE

EHA Library, Liri Seraj, 324166

RETROSPECTIVE ANALYSIS OF ROMIPLOSTIN IN SEVERE MEDULLARY APLASIA

EHA Library, Ana Rosa Carranco Falcón, 324167

BONE MARROW METASTASIS: A CASE SERIES

EHA Library, Siew Lian Chong, 324168

GENETIC LESIONS IN CLL PATIENTS WITH STEREOTYPE ANTIGENIC RECEPTORS MOST COMMON IN RUSSIA.

EHA Library, Bella Biderman, 324169

TARGETED MULTIGENE PANEL: NEXT-GENERATION SEQUENCING IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Maria Mikhaleva, 324170

CLINICAL FEATURES OF LARGE GRANULAR LYMPHOCYTIC LEUKEMIA-ASSOCIATED PURE RED CELL APLASIA: RESULTS FROM A SINGLE CENTER IN CHINA

EHA Library, Meili Ge, 324171

A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED WITH VENETOCLAX IN THE REAL-LIFE SETTING IN SPAIN (VENARES)

EHA Library, Christelle Ferra, 324172

COMPREHENSIVE CARDIAC EVALUATION REVEALS NO INCREASE IN VENTRICULAR ARRHYTHMIAS IN PATIENTS ON CHRONIC IBRUTINIB THERAPY – A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES

EHA Library, Igor Aurer, 324173

PROGNOSTIC VALUE OF IGHV MUTATIONAL STATE AT DIAGNOSIS FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Cristina Bilbao-Sieyro, 324174

FEATURES OF THE DIRECT ANTIGLOBULIN TEST AND THEIR ROLE IN THE DEVELOPMENT OF IMMUNE HEMOLYSIS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Elena Poponina, 324175

COMPARATIVE ASSESSMENT OF PROGNOSTIC MODELS FOR ASYMPTOMATIC CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS IN BINET STAGE A: EVALUATION IN CHINESE HAN COHORT

EHA Library, Huayuan Zhu, 324176

FEASIBILITY OF MEASURING ADHERENCE TO ORAL ONCOLYTICS IN ROUTINE CLINICAL PRACTICE: A PILOT STUDY IN OLDER ADULTS WITH LYMPHOID DISORDERS

EHA Library, Othman Salim Akhtar, 324177

PROGNOSTIC VALUE OF APOLIPOPROTEIN A IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Xiaoya Yun, 324178

THЕ EFFICACY OF FRONT-LINE CHEMOIMMUNOTHERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE, AND RITUXIMAB (FCR) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN REAL CLINICAL PRACTICE

EHA Library, Elena Kataeva, 324179

PATIENT PERSPECTIVES OF CHRONIC LYMPHOCYTIC LEUKEMIA & DISEASE RELATED OUTCOMES – A QUALITATIVE STUDY

EHA Library, Drupad HS, 324180

OUTCOMES IN PATIENTS WITH FOLLICULAR LYMPHOMA AND CHRONIC LYMPHOID LEUKEMIA RECEIVING OBINUTUZUMAB, IN THE SETTING OF COVID19 INFECTION

EHA Library, Nora Çollaku, 324181

ATYPICAL CHRONIC LYMPHOCYTIC LEUKEMIA: A COMPARATIVE MORPHOLOGICAL AND IMMUNOPHENOTYPIC STUDY

EHA Library, Margarita Guenova, 324182

PROSID STUDY: EVALUATING EFFICACY AND SAFETY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) 10% IN PRIMARY INFECTION PROPHYLAXIS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA – STUDY DESIGN

EHA Library, Oliver Cornely, 324183

PRETREATMENT NEUTROPENIA IN CLL PATIENTS IS ASSOCIATED WITH HIGH INFECTION RISK AND PREDICTS TREATMENT INITIATION WITHIN ONE YEAR.

EHA Library, Odit Gutwein, 324184

SUBCUTANEOUS IMMUNOGLOBULINS USE IN IMMUNODEFICIENCY SECONDARY TO CHRONIC LYMPHOCYTIC LEUKAEMIA: MONOCENTRIC EXPERIENCE IN COVID-19 ERA

EHA Library, Idanna Innocenti, 324185

EVALUATION OF ADVERSE EFFECTS OF IBRUTINIB: EXPERIENCE FROM A NORTHERN HOSPITAL OF SPAIN

EHA Library, Laura Escalada González, 324186

CD38 EXPRESSION AND CD19/CD5 CO-EXPRESSION IN CLL PATIENTS WITH DIFFERENT RESPONSES TO IMMUNOCHEMOTHERAPY

EHA Library, Tetiana Perekhrestenko, 324187

TYROSINE KINASE INHIBITORS DOWNREGULATE MIRNA EXPRESSION IN K562 CELL LINE

EHA Library, Julian Matias Freue, 324188

PATTERN OF MINIMAL RESIDUAL DISEASE IN TUNISIAN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Rim Frikha, 324189

MI-30-B AS A HOUSEKEEPING GENE POR MIRNA QPCR QUANTIFICATION IN CHRONIC MYELOID LEUKEMIA

EHA Library, Julian Matias Freue, 324190

STUDY OF TELOMERE LENGTH IN PATIENTS WITH CHRONIC MYELOLEUKOSIS

EHA Library, Anna Lyamkina, 324191

PULMONARY HYPERTENSION IN NEWLY DIAGNOSED AND TYROSINE KINASE INHIBITOR-TREATED PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Ik-Chan Song, 324192

KARYOTYPING CML PATIENTS IN TANZANIA USING DRY SPOT CARDS: A FEASIBLE AND NECESSARY DIAGNOSTIC PERFORMANCE FOR BETTER TREATMENT OUTCOME

EHA Library, Oliver Henke, 324193

E13A2, E14A2 TRANSCRIPTS: DO THEY HAVE A DIFFERENT IMPACT ON OUTCOME IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA?

EHA Library, Maria Garofalaki, 324194

CHRONIC MYELOID LEUKEMIA – THE CHALLENGE OF FRONTLINE TKI SELECTION 20 YEARS AFTER IMATINIB

EHA Library, Ioannis TSONIS, 324195

A MULTICENTER REAL-WORD EVIDENCE STUDY IN THE SWISS TREATMENT LANDSCAPE OF CHRONIC MYELOID LEUKEMIA

EHA Library, Stefan Balabanov, 324196

IMPACT OF LOW-DOSES TKIS IN THE RESPONSE OF CHRONIC PHASE CML PATIENTS: A 20-YEAR RETROSPECTIVE ANALYSIS.

EHA Library, Lucia Martínez Tobar, 324197

RETROSPECTIVE REAL-WORLD COMPARISON OF CLINICAL AND ECONOMIC BURDEN BETWEEN FIRST-GENERATION AND SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKIS) IN CHRONIC MYELOID LEUKEMIA (CML)

EHA Library, Alexander Russell-Smith, 324198

TREATMENT SELECTION IN CML: EFFECT OF ONLINE EDUCATION ON CLINICIAN KNOWLEDGE AND CONFIDENCE

EHA Library, Amanda Taylor, 324199

CLINICAL CHARACTERISTICS, DISEASE EVOLUTION AND SURVIVAL IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA, BCR-ABL-1+ AND MUTATION T315I

EHA Library, Veselina Goranova, 324200

TREATMENT OF CHRONIC MYELOID LEUKEMIA IN CHILDREN WITH TYROSIN KINASE INHIBITORS

EHA Library, Nihal karadaş, 324201

QTC PROLONGATION AND SUDDEN CARDIAC DEATH AS A MANIFESTATION OF CARDIOTOXICITY

EHA Library, Lyudmila Makeeva, 324202

THE DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA: THE IMPACT OF ELN GUIDELINES ON CLINICAL PRACTICE IN A DISTRICT GENERAL HOSPITAL

EHA Library, Muttuswamy Sivakumaran, 324203

DOSE REDUCTION OF ITKS IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. RETROSPECTIVE STUDY OF A SINGLE CENTER EXPERIENCE: SAFETY, EFFICIENCY AND ECONOMIC IMPACT.

EHA Library, Fernando Marco De Lucas, 324204